| RS183336802 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1833371664 |
OPTN
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 12, Amyotrophic lateral sclerosis type 12 |
| RS183342534 |
D2HGDH
|
Health Risk |
Conflicting classifications of pathogenicity |
D-2-hydroxyglutaric aciduria 1, Inborn genetic diseases |
| RS1833438306 |
OPTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 12, Glaucoma 1 |
| RS1833442352 |
KCNT1
|
Health Risk |
Likely pathogenic |
Autosomal dominant nocturnal frontal lobe epilepsy 5, Autosomal dominant nocturnal frontal lobe epilepsy 5 |
| RS1833451208 |
OPTN
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 12, Amyotrophic lateral sclerosis type 12 |
| RS183345423 |
MACF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS183345998 |
ABHD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Triglyceride storage disease with ichthyosis, Triglyceride storage disease with ichthyosis |
| RS1833482631 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS183349235 |
TBCD
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome, Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome |
| RS183350210 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS183354017 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS183355578 |
RFX6
|
Health Risk |
Pathogenic |
— |
| RS183355603 |
SMC1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS1833579629 |
GRIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS1833594325 |
GRIN1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS183359489 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Intellectual disability |
| RS1833598160 |
GRIN1
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1833598892 |
AGTPBP1
|
Health Risk |
Pathogenic |
Neurodegeneration, childhood-onset |
| RS1833614590 |
GRIN1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Intellectual disability |
| RS1833614725 |
GRIN1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS1833615155 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1833616245 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1833621434 |
GRIN1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS1833621750 |
GRIN1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS1833622746 |
DNM1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 31A |
| RS183362306 |
KANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
KANK1-related disorder, KANK1-related disorder |
| RS183362649 |
MYO18B
|
Health Risk |
Conflicting classifications of pathogenicity |
MYO18B-related disorder, Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome |
| RS1833635820 |
GRIN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Neurodevelopmental disorder with or without hyperkinetic movements and seizures |
| RS1833643967 |
INVS
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Nephronophthisis |
| RS183367929 |
TTC21B
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 12, Asphyxiating thoracic dystrophy 4 |
| RS1833698471 |
GRIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Neurodevelopmental disorder with or without hyperkinetic movements and seizures |
| RS183372450 |
RSPH4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 11, Primary ciliary dyskinesia |
| RS183373024 |
PRNCR1
|
Health Risk |
association |
Familial prostate cancer, Familial prostate cancer |
| RS183377804 |
LRP5
|
Health Risk |
Conflicting classifications of pathogenicity |
6 conditions, 6 conditions |
| RS1833814168 |
INVS
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS183383266 |
SAG
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1833833144 |
KCNT1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 14 |
| RS1833833523 |
LAMC3
|
Health Risk |
Likely pathogenic |
LAMC3-related disorder, LAMC3-related disorder |
| RS183387994 |
HADH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS183390670 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 2, Inborn genetic diseases |
| RS183392900 |
CEP164
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 15, Inborn genetic diseases |
| RS1833929015 |
FKTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1X, Dilated cardiomyopathy 1X |
| RS1833941275 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS183394803 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS1833955862 |
UBAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia 80, autosomal dominant |
| RS183395856 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 5, primary |
| RS183396486 |
AMT
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycine encephalopathy, Glycine encephalopathy |
| RS183398279 |
ANKRD26
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, ANKRD26-related disorder |
| RS183398286 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypercholesterolemia |
| RS183398940 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS1833990360 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS1833994284 |
WDR37
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurooculocardiogenitourinary syndrome, Neurooculocardiogenitourinary syndrome |
| RS1834041329 |
IARS1
|
Health Risk |
Pathogenic |
— |
| RS1834044297 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS183406496 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 2, ABCB11-related disorder |
| RS1834105260 |
COL27A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1834107819 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS183412440 |
SAG
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS183413469 |
OBSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
3M syndrome 2, Inborn genetic diseases |
| RS183413880 |
CCDC39
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 14 |
| RS183415577 |
ASCC1
|
Health Risk |
Pathogenic |
Spinal muscular atrophy with congenital bone fractures 2, Spinal muscular atrophy with congenital bone fractures 2 |
| RS183419371 |
RPGRIP1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 8, Meckel syndrome |
| RS183427173 |
KCNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome 6 |
| RS183431253 |
CDH23
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Usher syndrome type 1D |
| RS1834346707 |
TUBB8
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 2, Oocyte maturation defect 2 |
| RS1834347552 |
TUBB8
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 2, Oocyte maturation defect 2 |
| RS1834348631 |
TUBB8
|
Health Risk |
Pathogenic |
Oocyte maturation defect 2, Oocyte maturation defect 2 |
| RS1834349280 |
TUBB8
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 2, Oocyte maturation defect 2 |
| RS1834349710 |
TUBB8
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 2, Oocyte maturation defect 2 |
| RS1834349844 |
TUBB8
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 2, Oocyte maturation defect 2 |
| RS1834350042 |
TUBB8
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 2, Oocyte maturation defect 2 |
| RS1834351540 |
TUBB8
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 2, Oocyte maturation defect 2 |
| RS183435240 |
GNPTAB
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS183435741 |
LPIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoinflammatory syndrome, Majeed syndrome |
| RS1834359656 |
TUBB8
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 2, Oocyte maturation defect 2 |
| RS1834371028 |
TUBB8
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 2, Oocyte maturation defect 2 |
| RS1834373127 |
TUBB8
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 2, Oocyte maturation defect 2 |
| RS1834375493 |
TUBB8
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 2, Oocyte maturation defect 2 |
| RS1834375618 |
TUBB8
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 2, Oocyte maturation defect 2 |
| RS1834382153 |
TUBB8
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 2, Oocyte maturation defect 2 |
| RS1834414619 |
TUBB8
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 2, Oocyte maturation defect 2 |
| RS1834422689 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS1834422790 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS1834431047 |
ANKS6
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 16, Nephronophthisis 16 |
| RS1834431706 |
ANKS6
|
Health Risk |
Likely pathogenic |
Nephronophthisis 16, Nephronophthisis 16 |
| RS183443558 |
TRAF3
|
Health Risk |
Conflicting classifications of pathogenicity |
Herpes simplex encephalitis, susceptibility to |
| RS1834464693 |
LRSAM1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS1834465099 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS183449855 |
PEX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder 4A (Zellweger) |
| RS183455339 |
TBCD
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome, Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome |
| RS183455719 |
ATP1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Migraine, familial hemiplegic |
| RS183456651 |
HAX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kostmann syndrome, Kostmann syndrome |
| RS1834577610 |
VPS13A
|
Health Risk |
Pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS1834584602 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS1834600064 |
NUP214
|
Health Risk |
Likely pathogenic |
— |
| RS183460108 |
PEX5
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 2A (Zellweger), Peroxisome biogenesis disorder 2A (Zellweger) |
| RS1834606114 |
UPF2
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS1834650809 |
LINS1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS183465983 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |